Hongtao Tian

Title: Innovations of Hongtao Tian in Pharmaceutical Chemistry

Introduction

Hongtao Tian is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative research and development of novel compounds. His work focuses on the creation of compounds that have potential therapeutic applications, especially in the treatment of cancer.

Latest Patents

Hongtao Tian holds a patent for an isoindoline compound, which includes a preparation method, pharmaceutical composition, and its uses. The patent describes a polysubstituted isoindoline compound, which is a class of novel CRL4E3 ubiquitin ligase modulators. This compound exhibits stronger antitumor activity and a broader antitumor spectrum, making it a promising candidate for drug development aimed at treating CRL4E3 ligase-related diseases. He has 1 patent to his name.

Career Highlights

Hongtao Tian is affiliated with the Chinese Academy of Sciences, where he conducts his research. His work has garnered attention for its potential impact on cancer treatment and drug development. His innovative approach to creating new pharmaceutical compounds has positioned him as a key figure in his field.

Collaborations

Hongtao Tian collaborates with notable colleagues, including Xiaohua Chen and Jia Li. These collaborations enhance the research efforts and contribute to the advancement of their shared goals in pharmaceutical innovation.

Conclusion

Hongtao Tian's contributions to the field of pharmaceutical chemistry, particularly through his patented isoindoline compound, highlight his role as an influential inventor. His work not only advances scientific knowledge but also holds promise for future therapeutic applications.